Wellgistics Health Launches Medical Food for Muscle Loss in GLP-1 Weight Loss Patients | NewsOut

Healthcare and biotech investors: Wellgistics Health, a health information technology company integrating AI pharmacy optimization and blockchain-enabled pharmacy platforms, announced the launch of Fawzett, a medical food designed to address muscle loss associated with GLP-1 weight loss therapies.

Reporting from the New York Stock Exchange, Jane King explains the product will initially be offered to physicians and pharmacists who prescribe GLP-1 medications. The formulation has been evaluated in controlled clinical studies involving patients with conditions including type 2 diabetes, heart failure, and COPD, and will be distributed through the company’s affiliated pharmacy network.

#WellgisticsHealth
#GLP1
#WeightLossTherapy
#MedicalFood
#HealthcareInnovation
#PharmacyTechnology
#BlockchainHealth
#AIPharmacy
#MuscleLoss
#DigitalHealth
#JaneKing
#NewsOut